PHLATE

Health benefits

In accordance with the Classification of “Drinking Natural Mineral Waters” - siliceous hydro-carbonate magnesium-calcium-sodium (calcium-sodium-magnesium) water "Phlate" belongs to Group IV and is indicated for the following diseases:

Endocrine system diseases, nutritional disorders and metabolic disorders:
- Diabetes mellitus (insulin-dependent and non-insulin dependent), impaired glucose tolerance;
- Obesity (alimentary);
- Disorders of lipoprotein metabolism;
- Disorders of salt metabolism.


Diseases of the digestive system:
- Reflux esophagitis;
- Chronic gastritis with normal and increased gastric secretory function;
- Gastric ulcer and 12 duodenal ulcer;
- Bowel diseases: irritable bowel syndrome with diarrhea; irritable bowel syndrome with constipation;
- Liver diseases: chronic viral hepatitis; toxic and drug-induced liver damage; fatty degeneration of the liver;
- Diseases of the gallbladder, biliary tract, pancreas: chronic cholecystitis, cholangitis, cholesterosis of the gallbladder;
cholelithiasis; chronic pancreatitis,
Disorders of the digestive system after surgical interventions: syndromes of the operated stomach after surgery for peptic ulcer disease; post-cholecystectomy syndromes.
Diseases of the genitourinary system: chronic pyelonephritis, urolithiasis, other diseases (chronic cystitis, urethritis, trigonite).

Medical indications for the therapeutic use of the mineral drinking medicinal table water PHLATE, as defined according to the GOST R 54316-2011 edition:
- Diseases of the esophagus (esophagitis, gastroesophageal reflux disease);
- Chronic gastritis with normal and increased gastric secretory function;
- Gastric ulcer and 12 duodenal ulcer;
- Bowel diseases (irritable bowel syndrome, bowel dyskinesia);
- Diseases of the liver, gallbladder and biliary tract;
- Diseases of the pancreas (chronic pancreatitis);
- Disorders of the digestive system after surgical interventions for gastric ulcer; post-cholecystectomy syndromes;
- Metabolic diseases (diabetes mellitus, obesity, impaired salt and lipid metabolism);
- Diseases of the urinary tract (chronic pyelonephritis, urolithiasis, chronic cystitis, urethritis) The low-mineralized medicinal table water "PHLATE" meets the requirements for mineral drinking water and is beneficial for human health and meets the requirements of GOST R 54316-2011 and the Technical Regulation of the Customs Union TR CU 021/2011. In terms of safety, it meets the conditions of Appendix 1 to Section 21 of Chapter II of the Unified Sanitary-Epidemiological and Hygienic Requirements for Goods Subjected to Sanitary-Epidemiological Supervision (Control) and Appendix 2 of Section 1.7 of the Technical Regulation of the Customs Union TR CU 021/2011